Iridex IRIX
NASDAQ IRIX
$0.76 -0.02 (-2.72%)
As of: Aug 20, 2026 · 3:54 PM EDT

Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012)

Iridex (IRIX) posted quarterly Liabilities from Discontinued Operations of 67000.0 for Q3 2012, down 15.19% quarter-over-quarter from 79000.0 in Q2 2012.

Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012) Analysis & Trends

Iridex's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 67000.0 for Q3 2012.

  • In Q3 2012, Liabilities from Discontinued Operations changed N/A year-over-year to 67000.0; the TTM figure through Sep 2012 stood at 67000.0 (changed N/A YoY), while the FY2011 annual figure was 2663000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations for Q3 2012 stood at 67000.0, down from 79000.0 in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was 2663000.0 in Q4 2011, with the low at 67000.0 in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Iridex 13.27 Mn 8.59 Mn 4.30 Mn

Historic Data

Download Data
DateValue
Sep 29, 2012 67,000.00
Sep 29, 2012 67,000.00
Jun 30, 2012 79,000.00
Jun 30, 2012 79,000.00
Mar 31, 2012 259,000.00
Mar 31, 2012 259,000.00
Dec 31, 2011 2.66 Mn
Dec 31, 2011 2.66 Mn